« Back
Home /
Thalidomide

Thalidomide

Manufacturer	TargetMol
Category	Oncology Reagents & Chemicals Molecules By Organ Bladder Cancer
Type	Molecules
Specific against	other
Amount	2mg
Item no.	TMO-T0213-2mg
Targets	TNF
CASRN	50-35-1
eClass 6.1	32169090
eClass 9.0	32169090
Available
Description	Thalidomide can directly inhibit angiogenesis induced by bFGF or VEGF in vivo.
Formulate	C13H10N2O4
Shipping temperature	Cool Pack
Smeles	O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC= C12
Storage Temperature	-20° C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 2mg

available

Delivery expected until 5/23/2024